Literature DB >> 24652041

The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media.

Arwa Kurabi1, Jasmine Lee2, Chelsea Wong2, Kwang Pak3, Hal M Hoffman4, Allen F Ryan5, Stephen I Wasserman6.   

Abstract

This study was designed to understand the contribution of the inflammasome and IL-1β activation in otitis media (OM). We examined the middle ear (ME) response to non-typeable Haemophilus influenzae (NTHi) in wild type (WT) mice using gene microarrays and a murine model of acute OM. Expression of members of the NOD domain-like receptor family of inflammasome genes was significantly up-regulated early in NTHi infection of the ME, potentially activating specific downstream regulatory cascades that contribute to the proliferative inflammatory response observed during OM. Expression of the pro-forms of the inflammasome targets IL-1β and IL-18 were also up-regulated. To evaluate the role of inflammasome-mediated cytokine maturation, NTHi-induced OM was examined in Asc(-/-)-deficient mice and compared with that seen in WT mice. Mice lacking the Asc gene showed near absence of IL-1β maturation in the ME and a reduction in leukocyte recruitment and infiltration to the cavity, and their macrophages exhibited reduced phagocytosis of NTHi. These inflammatory defects were linked to an increase in the degree and duration of mucosal epithelial hyperplasia in the ME of Asc(-/-) mice, as well as a delay in bacterial clearance from their MEs. These data demonstrate an important role for the inflammasome and cytokine processing in the course and resolution of OM.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  IL-1β; NTHi; cytokine; inflammation; macrophage; middle ear

Mesh:

Substances:

Year:  2014        PMID: 24652041      PMCID: PMC4379507          DOI: 10.1177/1753425914526074

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  61 in total

Review 1.  IL-1 pathways in inflammation and human diseases.

Authors:  Cem Gabay; Céline Lamacchia; Gaby Palmer
Journal:  Nat Rev Rheumatol       Date:  2010-02-23       Impact factor: 20.543

2.  Role of interleukin-1beta in a murine model of otitis media with effusion.

Authors:  T Watanabe; T Hirano; M Suzuki; Y Kurono; G Mogi
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-06       Impact factor: 1.547

3.  The role of vascular endothelial growth factors and fibroblast growth factors in angiogenesis during otitis media.

Authors:  Jacob Husseman; Sean D Palacios; Alexander Z Rivkin; Heinz Oehl; Allen F Ryan
Journal:  Audiol Neurootol       Date:  2011-11-19       Impact factor: 1.854

Review 4.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

Review 5.  ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome.

Authors:  Sanjeev Mariathasan
Journal:  Microbes Infect       Date:  2007-01-27       Impact factor: 2.700

6.  Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.

Authors:  Takashi Hirano; Satoru Kodama; Keigo Fujita; Kazuhiko Maeda; Masashi Suzuki
Journal:  FEMS Immunol Med Microbiol       Date:  2007-02

7.  NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection.

Authors:  Shanshan Cai; Sanjay Batra; Nobuko Wakamatsu; Pal Pacher; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-04-30       Impact factor: 5.422

Review 8.  Inflammasome and IL-1beta-mediated disorders.

Authors:  Hal M Hoffman; Alan A Wanderer
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

9.  TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Kenshi Yamasaki; Chun-Fang Cheng; Nicholas J Webster; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2009-07-08       Impact factor: 2.680

10.  NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling.

Authors:  Irving C Allen; Justin E Wilson; Monika Schneider; John D Lich; Reid A Roberts; Janelle C Arthur; Rita-Marie T Woodford; Beckley K Davis; Joshua M Uronis; Hans H Herfarth; Christian Jobin; Arlin B Rogers; Jenny P-Y Ting
Journal:  Immunity       Date:  2012-04-12       Impact factor: 31.745

View more
  11 in total

Review 1.  Panel 3: Genetics and Precision Medicine of Otitis Media.

Authors:  Jizhen Lin; Lena Hafrén; Joseph Kerschner; Jian-Dong Li; Steve Brown; Qing Y Zheng; Diego Preciado; Yoshihisa Nakamura; Qiuhong Huang; Yan Zhang
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

2.  A2ML1 and otitis media: novel variants, differential expression, and relevant pathways.

Authors:  Eric D Larson; Jose Pedrito M Magno; Matthew J Steritz; Erasmo Gonzalo D V Llanes; Jonathan Cardwell; Melquiadesa Pedro; Tori Bootpetch Roberts; Elisabet Einarsdottir; Rose Anne Q Rosanes; Christopher Greenlee; Rachel Ann P Santos; Ayesha Yousaf; Sven-Olrik Streubel; Aileen Trinidad R Santos; Amanda G Ruiz; Sheryl Mae Lagrana-Villagracia; Dylan Ray; Talitha Karisse L Yarza; Melissa A Scholes; Catherine B Anderson; Anushree Acharya; Samuel P Gubbels; Michael J Bamshad; Stephen P Cass; Nanette R Lee; Rehan S Shaikh; Deborah A Nickerson; Karen L Mohlke; Jeremy D Prager; Teresa Luisa G Cruz; Patricia J Yoon; Generoso T Abes; David A Schwartz; Abner L Chan; Todd M Wine; Eva Maria Cutiongco-de la Paz; Norman Friedman; Katerina Kechris; Juha Kere; Suzanne M Leal; Ivana V Yang; Janak A Patel; Ma Leah C Tantoco; Saima Riazuddin; Kenny H Chan; Petri S Mattila; Maria Rina T Reyes-Quintos; Zubair M Ahmed; Herman A Jenkins; Tasnee Chonmaitree; Lena Hafrén; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  Hum Mutat       Date:  2019-05-21       Impact factor: 4.878

Review 3.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

4.  Both canonical and non-canonical NF-κB activation contribute to the proliferative response of the middle ear mucosa during bacterial infection.

Authors:  Chang Gun Cho; Kwang Pak; Nicholas Webster; Arwa Kurabi; Allen F Ryan
Journal:  Innate Immun       Date:  2016-09-23       Impact factor: 2.680

Review 5.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

6.  Role of Surfactant Protein D in Experimental Otitis Media.

Authors:  Osama Abdel-Razek; Tianyi Liu; Xinghua Chen; Qiushi Wang; Gautam Vanga; Guirong Wang
Journal:  J Innate Immun       Date:  2021-02-08       Impact factor: 7.349

7.  The transcriptome of a complete episode of acute otitis media.

Authors:  Michelle Hernandez; Anke Leichtle; Kwang Pak; Nicholas J Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Genomics       Date:  2015-04-03       Impact factor: 3.969

8.  Lack of the hyaluronan receptor CD44 affects the course of bacterial otitis media and reduces leukocyte recruitment to the middle ear.

Authors:  Hyun Woo Lim; Kwang Pak; Arwa Kurabi; Allen F Ryan
Journal:  BMC Immunol       Date:  2019-06-21       Impact factor: 3.615

Review 9.  Current Understanding of Host Genetics of Otitis Media.

Authors:  Ruishuang Geng; Qingzhu Wang; Eileen Chen; Qing Yin Zheng
Journal:  Front Genet       Date:  2020-02-07       Impact factor: 4.599

10.  A Bacterial Epigenetic Switch in Non-typeable Haemophilus influenzae Modifies Host Immune Response During Otitis Media.

Authors:  Frank H Robledo-Avila; Juan de Dios Ruiz-Rosado; Santiago Partida-Sanchez; Kenneth L Brockman
Journal:  Front Cell Infect Microbiol       Date:  2020-10-23       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.